cancer clinical trials in new haven, CT

Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma

Lobradimil and Carboplatin in Treating Children With Brain Tumors

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Brain and Central Nervous System Tumors

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut 06520-8064

Leukemia

Combination Chemotherapy in Treating Patients With Advanced Cancer

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Unspecified Adult Solid Tumor, Protocol Specific

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Yale University
New Haven, Connecticut 06520

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Mixed Oligoastrocytoma, Malignant Astrocytoma

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Yale Cancer Center
New Haven, Connecticut 06520-8028

Lymphoma

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Brain and Central Nervous System Tumors

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Metastatic Cancer

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut 06520-8064

Sarcoma

Melatonin and Radiation Therapy in Treating Patients With Brain Metastases

Hospital of St. Raphael
New Haven, Connecticut 06511

Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Prostate Cancer

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Colorectal Cancer

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Cervical Cancer

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

Yale Comprehensive Cancer Center

Trial Locations
Yale Comprehensive Cancer Center
Hospital of St. Raphael

Carcinoma of Unknown Primary

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

Yale University
New Haven, Connecticut 06520

Breast Neoplasms, Breast Cancer, Metastasis

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Yale University School Of Medicine
New Haven, Connecticut 06520

Non-Small Cell Lung Cancer

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Yale Comprehensive Cancer Center

Trial Locations
Yale Comprehensive Cancer Center
Hospital of Saint Raphael

Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific

Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Ovarian Cancer, Primary Peritoneal Cavity Cancer

Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut 06520-8064

Leukemia

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Yale University School Of Medicine
New Haven, Connecticut 06520

Multiple Myeloma

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut 06520-8064

Pancreatic Cancer

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Lung Cancer

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Yale Cancer Center
New Haven, Connecticut 06520-8028

Cervical Cancer

Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

Yale University School Of Medicine
New Haven, Connecticut 06520

Hepatitis B

Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

Yale University School Of Medicine
New Haven, Connecticut 06520

Melanoma, Malignant Metastatic Melanoma

Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Colorectal Cancer

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Yale Cancer Center
New Haven, Connecticut 06520-8028

Vulvar Cancer

A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies

Yale University
New Haven, Connecticut 06520

Unspecified Adult Solid Tumor, Protocol Specific

Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy in Treating Children With Intraocular Retinoblastoma

Yale University
New Haven, Connecticut 06520

Intraocular Retinoblastoma

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Yale University
New Haven, Connecticut 06520

Hepatocellular Carcinoma, Liver Cancer

The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme

Yale University School of Medicine - Department of Neurosurgery
New Haven, Connecticut 06520

Glioblastoma Multiforme

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

Yale University School Of Medicine
New Haven, Connecticut 06520

Breast Cancer, Metastases

Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Yale University
New Haven, Connecticut 06520

Glioblastoma Multiforme

Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer

Yale Cancer Center
New Haven, Connecticut 06520-8028

Colorectal Cancer

Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia

Yale Cancer Center
New Haven, Connecticut 06520-8028

Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Yale Comprehensive Cancer Center
New Haven, Connecticut 06520-8028

Endometrial Cancer

Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut 06520-8064

Ovarian Cancer, Primary Peritoneal Cavity Cancer

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Yale Cancer Center
New Haven, Connecticut 06520-8028

Cervical Cancer

A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas

Yale University School Of Medicine
New Haven, Connecticut 06520

Soft Tissue Sarcoma

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Yale University School Of Medicine
New Haven, Connecticut 06520

Biliary Tract Cancer

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

The Savin Center P.C.
New Haven, Connecticut 06511

Psoriatic Arthritis

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut 06520-8064

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

Yale University School of Medicine - Oncology Outpatient Clinic
New Haven, Connecticut 06520

Melanoma, Metastases

Views of Cancer Patients Regarding Financial Conflicts of Interest

Yale University
New Haven, Connecticut 06520

Neoplasms

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

Yale Cancer Center
New Haven, Connecticut 06520-8028

Lymphoma

Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma

Yale
New Haven, Connecticut 06520

Large Cell Lymphoma

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

Yale University School Of Medicine
New Haven, Connecticut 06520

Lymphoma, Non-Hodgkin

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Yale University School Of Medicine
New Haven, Connecticut 06520

Multiple Myeloma

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Yale Cancer Center
New Haven, Connecticut 06520-8028

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Yale Cancer Center
New Haven, Connecticut 06520-8028

Lymphoma, Leukemia, Cancer

A Study of Anal Cancer Development in HIV Infected People

Yale University

Trial Locations
Yale University
CRI-Brooklin
CRI-Springfield

HIV Infections, Anus Neoplasms

Join the directory

Join the Community

Join the Directory